CLOVER HEALTH INVESTMENTS, CORP. /DE·4

Jul 17, 5:26 PM ET

Reynoso Jamie L. 4

Research Summary

AI-generated summary

Updated

Clover Health (CLOV) Jamie L. Reynoso Sells 4,839 Shares

What Happened Jamie L. Reynoso, CEO — Medicare Advantage at Clover Health Investments, sold 4,839 shares on July 17, 2026. The sales generated approximately $21,921, reported at a weighted-average price of $4.53 per share (individual trade prices ranged $4.35–$4.63). This was a sale (S), not a purchase.

Key Details

  • Transaction date: 2026-07-17 (reported same day).
  • Shares sold: 4,839; weighted-average price: $4.53; total proceeds reported: $21,921.
  • Price range: $4.35 to $4.63 across multiple trades; filer can provide breakdown by price on request (see footnote).
  • Footnote: Sale was executed pursuant to a Rule 10b5-1 trading plan adopted March 12, 2026.
  • Shares owned after transaction: Not stated in the provided Form 4.
  • Filing timeliness: Reported for the same period date (no late filing indicated).

Context

  • Sale under a 10b5-1 plan indicates the trades were preplanned; this is a routine disposition rather than an ad hoc sale. For retail investors, purchases generally convey stronger affirmative signals than routine sales. No options exercise, gift, or tax-withholding event is reported in this filing.